2020 Meetings Abstracts: AACR Special Conference on Advancing Precision Medicine Drug Development: Incorporation of Real-World Data and Other Novel Strategies January 9–12, 2020; San Diego, CA ...

Author's Affiliation: Molecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center, New York, New York Corresponding Author: Ting-Chao Chou, Preclinical Pharmacology Core ...

Department of Pharmacology and University of Colorado Cancer Center, University of Colorado at Denver and Health Sciences Center, Aurora, Colorado Search for other works by this author on: ...

1Novelty Nobility, lnc., Seongnam-si, Republic of Korea.

1Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland. *Corresponding Author: Luckson N. Mathieu, Office of Oncologic ...

Cancer Res (2022) 82 (12_Supplement): 3595. Combination treatment with RMC-6291 and SHP2 or SOS1 inhibitors was well tolerated in preclinical models and further increased anti-tumor activity, likely ...

1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. 6Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. Search ...

1Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay (IIT Bombay), Mumbai, Maharashtra, India.

1Philochem AG, Otelfingen, Zurich, Switzerland.

1Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. Search for other works by this author on: 1Human Oncology and Pathogenesis Program, Memorial Sloan ...

1Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, Wisconsin. 2Medical College of Wisconsin Cancer Center, Milwaukee, Wisconsin.

1Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.